ALLO-501,ALLO-501A,ALLO-647,Fludarabine,Cyclophosphamide
Allogene
['lymphoma', 'allogene therap', '$allo']
allogene therapeutics provides additional allo-501/501a phase 1 data in an oral presentation at the international conference on malignant lymphoma (icml) lugano - health stocks hub $allo 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2